ArticleAntimicrobial resistance and infection control2025
Aerosolization of Mycobacterium chelonae from heater-cooler-devices: a continuing risk of exposure during cardiac surgery.
Article in Antimicrobial resistance and infection control, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFollowing identification of widespread Mycobacterium chimaera infections in 2013 associated with aerosolization from Sorin heater-cooler-devices (HCD), microbiological monitoring of HCDs has become mandatory in Switzerland.
methodsSince 01/2016, four Maquet HCU40 (Getinge) HCDs have been in operation at the University Hospital Basel. Monthly water cultures for Gram-negative bacteria and mycobacteria were performed, including samples from two filling lines equipped with 0.2 μm water filters. Intermittent monthly air sampling for mycobacteria was conducted.
resultsBetween 01/2016 and 05/2018, various non-fermenting bacteria were cultured. Mycobacterium chelonae was first isolated in 06/2018 from HCD water tanks. Mycobacteria cultures from the filling lines remained negative. The first air sample positive for M. chelonae was collected in 12/2019. Despite intensified disinfection measures from 01/2022 onwards, M. chelonae could be cultured in air samples, collected at 30 cm and 120 cm height adjacent to three of the four running HCDs in 07/2022. Whole genome sequencing identified a cluster of isolates differing by a maximum of four single nucleotide polymorphisms. Despite extensive investigations, the source of M. chelonae remains undetermined. To date, no infections with M. chelonae have been related to the contaminated HCDs at our institution.
conclusionsOur data confirms the risk of aerosolization of non-tuberculous mycobacteria from HCDs, irrespective of HCD-design and manufacturer. These findings underscore the importance of routine microbiological surveillance, including both water and air sampling when HCDs are placed within the operation room to prevent exposure of the operating field to the air exhausts of HCDs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.